FindTrial
Sign In

The effect of hydrocolloid dressing (XtraSorb HCS) compared to silicon foam dressing (Mepilex) or alginate (Kaltostat) and semipermeable film (Tegaderm) on the donorsite after split thickness skin graft: a randomized controlled trial.

The effect of hydrocolloid dressing (XtraSorb HCS) compared to silicon foam dressing (Mepilex) or alginate (Kaltostat) and semipermeable film (Tegaderm) on the donorsite after split thickness skin graft: a randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29328
Enrollment
75
Registered
2015-09-17
Start date
2015-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with a donorsite after harvesting a split thickness skin graft usually experience pain, discomfort and sometimes develop infection. Keywords: donorsite

Interventions

Group 1: silicon foam dressing (Mepilex) Group 2: hydrocolloid dressing (XtraSorb HCS) Group 3: or alginate (Kaltostat) and semipermeable film (Tegaderm)

Sponsors

Antoni van Leeuwenhoek Plesmanlaan 121 1066 CX Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients older than 18 years after split thickness skin graft and signed informed consent.

Exclusion criteria

Exclusion criteria: < 18 years.

Design outcomes

Primary

MeasureTime frame
Re-epithelialization—

Secondary

MeasureTime frame
Patient comfort Infection Number of dressing changes—

Contacts

Public ContactStephanie de Jong

Plesmanlaan 121

sj.d.jong@nki.nl020-5129059 (06-50439906)

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)